PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.17%
Revenue growth similar to BRZE's 16.46%. Walter Schloss would see if both companies share industry tailwinds.
17.03%
Gross profit growth 1.25-1.5x BRZE's 15.38%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
19.09%
EBIT growth above 1.5x BRZE's 6.72%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
19.09%
Operating income growth above 1.5x BRZE's 6.72%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
18.38%
Net income growth above 1.5x BRZE's 4.72%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
23.53%
EPS growth of 23.53% while BRZE is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
23.53%
Diluted EPS growth of 23.53% while BRZE is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
5.82%
Slight or no buybacks while BRZE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
5.82%
Slight or no buyback while BRZE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-20.97%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-17.32%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.16%
We increase R&D while BRZE cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
1.66%
SG&A declining or stable vs. BRZE's 12.79%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.